Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 7
2013 4
2014 8
2015 7
2016 2
2017 5
2018 5
2019 6
2020 6
2021 6
2022 4
2023 5
2024 3
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 21871372

60 results

Results by year

Filters applied: . Clear all
Page 1
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.
Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D. Riggs PD, et al. J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903-14. doi: 10.1016/j.jaac.2011.06.010. Epub 2011 Aug 4. J Am Acad Child Adolesc Psychiatry. 2011. PMID: 21871372 Free PMC article. Clinical Trial.
Evidence-based Interventions for Youth With Concurrent Mental Health and Substance Use Disorders: A Scoping Review: Interventions fondées sur des données probantes pour les jeunes atteints de troubles concomitants de santé mentale et liés à l'usage de substances psychoactives : une étude de la portée.
Marshall T, Reeson M, Loverock A, Lewis AE, King I, Ilyas R, Dixon CC, Viste D, Azer B, Chow E, Safi F, Kennedy M, Abba-Aji A, Greenshaw AJ. Marshall T, et al. Can J Psychiatry. 2025 May;70(5):347-371. doi: 10.1177/07067437241300957. Epub 2025 Jan 6. Can J Psychiatry. 2025. PMID: 39763221 Free PMC article.
Reliability of Telepsychiatry Assessments Using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized Feasibility Study.
Kurokawa S, Nomura K, Hosogane N, Nagasawa T, Kawade Y, Matsumoto Y, Morinaga S, Kaise Y, Higuchi A, Goto A, Inada N, Kodaira M, Kishimoto T. Kurokawa S, et al. J Med Internet Res. 2024 Feb 19;26:e51749. doi: 10.2196/51749. J Med Internet Res. 2024. PMID: 38373022 Free PMC article. Clinical Trial.
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.
Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, Cubbin S, Deeley Q, Gudjonsson GH, Hill P, Hollingdale J, Jenden S, Johnson J, Judge D, Lewis A, Mason P, Mukherjee R, Nutt D, Roberts J, Robinson F, Woodhouse E, Cocallis K. Young S, et al. World J Psychiatry. 2023 Mar 19;13(3):84-112. doi: 10.5498/wjp.v13.i3.84. eCollection 2023 Mar 19. World J Psychiatry. 2023. PMID: 37033892 Free PMC article. Review.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ, Storm MRO, Pereira Ribeiro J, Skoog M, Groth C, Callesen HE, Schaug JP, Darling Rasmussen P, Huus CL, Zwi M, Kirubakaran R, Simonsen E, Gluud C. Storebø OJ, et al. Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2025 Dec 4;12:CD009885. doi: 10.1002/14651858.CD009885.pub4. PMID: 36971690 Free PMC article. Updated.
60 results